Orchard Therapeutics plc ORTX
Set alert
16.70 0.00 0.00%
At close · Jan 23
16.64 Day range 16.72
52-week range unavailable
- Open
- 16.65
- Prev close
- 16.70
- Mkt cap
- 380.11M
- Vol
- 372.35K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.64
- High
- 16.72
- Forward P/E
- -3.35
- Beta
- 0.55
- Short ratio
- 0.28
- Inst. own
- 103.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 4, 2024
- 50-d avg
- 16.44
- 200-d avg
- 10.11
- 1y target
- 16.00
Financial health
Altman Z-Score
-2.95 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -6.1×
FY 2016 5y median -4.5× FY 2022
P/S 6.8×
FY 2016 5y median 171× FY 2022
P/B 0.5×
FY 2016 5y median 1.1× FY 2022
P/FCF -0.6×
FY 2016 5y median -3.1× FY 2022
EV/EBITDA -0.2×
FY 2016 5y median -1.2× FY 2022
EV/Sales 5.3×
FY 2016 5y median 167× FY 2022
FCF Yield -174.2%
FY 2016 5y median -32.3% FY 2022
Profitability
Gross Margin 65.2%
FY 2016 5y median 67.0% FY 2022
Operating Margin -452.2%
FY 2016 5y median -6879.1% FY 2022
Net Margin -112.8%
FY 2016 5y median -6503.1% FY 2022
ROE -8.0%
FY 2016 5y median -54.6% FY 2022
ROIC -15.9%
FY 2016 5y median -48.8% FY 2022
ROA -3.6%
FY 2016 5y median -40.9% FY 2022
Growth (YoY)
Revenue 1346.4%
FY 2016 FY 2022
Operating Income 13.2%
FY 2016 FY 2022
EPS (diluted) 79.2%
FY 2016 FY 2022
Free Cash Flow 35.7%
FY 2016 FY 2022
Financial Health
Current Ratio 2.8×
FY 2016 5y median 6.3× FY 2022
Quick Ratio 2.7×
FY 2016 5y median 6.3× FY 2022
Debt / Equity 0.6×
FY 2016 5y median 0.3× FY 2022
Net Debt / EBITDA 0.1×
FY 2016 5y median -0.0× FY 2022
Interest Coverage -33.9×
FY 2016 5y median -53.3× FY 2022
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31